AU1366088A - Immunosuppressive peptides and methods of use - Google Patents
Immunosuppressive peptides and methods of useInfo
- Publication number
- AU1366088A AU1366088A AU13660/88A AU1366088A AU1366088A AU 1366088 A AU1366088 A AU 1366088A AU 13660/88 A AU13660/88 A AU 13660/88A AU 1366088 A AU1366088 A AU 1366088A AU 1366088 A AU1366088 A AU 1366088A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- immunosuppressive peptides
- immunosuppressive
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001506 immunosuppresive effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US750987A | 1987-01-28 | 1987-01-28 | |
US007509 | 1987-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1366088A true AU1366088A (en) | 1988-08-24 |
Family
ID=21726617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13660/88A Abandoned AU1366088A (en) | 1987-01-28 | 1988-01-25 | Immunosuppressive peptides and methods of use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0300031A4 (en) |
JP (1) | JPH01501939A (en) |
KR (1) | KR890700602A (en) |
AU (1) | AU1366088A (en) |
DK (1) | DK535988A (en) |
WO (1) | WO1988005783A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
SE8705197D0 (en) * | 1987-12-30 | 1987-12-30 | Jonas Blomberg | NEW PEPTIDES, TWO DIAGNOSTIC METHODS USING THE PEPTIDES AND A MEDICATION BASED ON THE PEPTIDES |
AU4616289A (en) * | 1988-12-13 | 1990-06-21 | Colorado State University Research Foundation | Prototype felv isolates for use in disease models and vaccines |
US5061786A (en) * | 1989-05-25 | 1991-10-29 | Genentech, Inc. | Biologically active polypeptides based on transforming growth factor-β |
US5268455A (en) * | 1989-05-25 | 1993-12-07 | Genentech, Inc. | Process for making biologically active polypeptides based on transforming growth factor-βsequences |
JP2807287B2 (en) * | 1989-10-13 | 1998-10-08 | 株式会社医学生物学研究所 | Peptides and their uses |
US5567805A (en) * | 1990-03-09 | 1996-10-22 | Administrators Of The Tulane Educational Fund | The cellular receptor for the CS3 peptide of human immunodeficiency virus |
FR2677654B1 (en) * | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT. |
JPH07506810A (en) * | 1992-02-10 | 1995-07-27 | デューク・ユニバーシティ | Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes that are self-antigens |
SE9202318L (en) * | 1992-08-10 | 1994-02-11 | Replico Medical Ab | New peptides, diagnostic antigens, their use, vaccines and drugs |
EP0743949B1 (en) | 1994-02-07 | 1999-12-15 | QIAGEN GmbH | Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
SE9403526D0 (en) | 1994-10-14 | 1994-10-14 | Astra Ab | New Peptides |
DZ1964A1 (en) * | 1995-01-13 | 2002-10-15 | Nika Health Products Ltd | New applications of a lysozyme dimer. |
SE9501067D0 (en) * | 1995-03-24 | 1995-03-24 | Astra Ab | New peptides |
US5994292A (en) * | 1995-05-31 | 1999-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon-inducible protein 10 is a potent inhibitor of angiogenesis |
JP2000508898A (en) * | 1996-04-12 | 2000-07-18 | アストラ・アクチエボラーグ | Cysteine-containing or methionine-containing peptides with immunomodulatory activity |
WO1998010792A1 (en) * | 1996-09-11 | 1998-03-19 | Prendergast Patrick T | Immune direction therapy |
SE9603468D0 (en) * | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
SE9603462D0 (en) * | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
SE9603461D0 (en) * | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
IT1307826B1 (en) * | 1999-12-16 | 2001-11-19 | Dipartimento Di Medicina Speri | DIAGNOSTIC METHOD FOR THE RECOGNITION OF NORMAL ELEUCEMIC MYELOID CELLS, LIGANDS USED IN THAT METHOD AND FORMULATIONS FOR USE |
US9777044B2 (en) | 2003-05-02 | 2017-10-03 | Centre National De La Recherche Scientifique (Cnrs) | GLUT-1 as a receptor for HTLV envelopes and its uses |
EP1648926B1 (en) | 2003-05-02 | 2013-07-03 | Centre National De La Recherche Scientifique (Cnrs) | Glut-1 as a receptor for htlv envelopes and its uses |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
US9791435B2 (en) | 2009-01-09 | 2017-10-17 | Centre National De La Recherche Scientifique | Receptor binding ligands, their use in the detection of cells with biological interest |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525300A (en) * | 1983-01-07 | 1985-06-25 | Japanese Foundation For Cancer Research | Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies |
GB8301928D0 (en) * | 1983-01-24 | 1983-02-23 | Nicholson B H | Process for producing polypeptides |
US4663436A (en) * | 1984-04-24 | 1987-05-05 | Scripps Clinic And Research Foundation | Leukemia-associated virus immunogen, vaccine and assay |
US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
KR910002374B1 (en) * | 1985-04-29 | 1991-04-20 | 제네틱 시스템즈 코포레이션 | Synthetic antigens for the detection of aids-relate disease |
-
1988
- 1988-01-25 WO PCT/US1988/000176 patent/WO1988005783A1/en not_active Application Discontinuation
- 1988-01-25 JP JP63502107A patent/JPH01501939A/en active Pending
- 1988-01-25 AU AU13660/88A patent/AU1366088A/en not_active Abandoned
- 1988-01-25 EP EP19880902271 patent/EP0300031A4/en not_active Withdrawn
- 1988-09-27 KR KR1019880701169A patent/KR890700602A/en not_active Application Discontinuation
- 1988-09-27 DK DK535988A patent/DK535988A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0300031A4 (en) | 1990-05-14 |
DK535988A (en) | 1988-11-25 |
EP0300031A1 (en) | 1989-01-25 |
WO1988005783A1 (en) | 1988-08-11 |
DK535988D0 (en) | 1988-09-27 |
JPH01501939A (en) | 1989-07-06 |
KR890700602A (en) | 1989-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1366088A (en) | Immunosuppressive peptides and methods of use | |
AU585180B2 (en) | Nor-statine and nor-cyclostatine polypeptides | |
AU3678489A (en) | Alloy and methods of use thereof | |
AU1925588A (en) | Blasting system and components therefor | |
AU3076189A (en) | Novel compositions and methods of use thereof | |
AU2472188A (en) | Multi-piece connector and receptacle therefor | |
AU4781693A (en) | Camptothecin analogues and methods of preparation thereof | |
AU1069688A (en) | Non natural demethylavermectins and process therefor | |
GB2216134B (en) | Membranes and methods of preparation thereof | |
AU9092091A (en) | Receptor recognition factor and methods of use thereof | |
AU6428890A (en) | Therapeutic peptides and proteins | |
AU4687189A (en) | Hydrophones and similar devices | |
AU633294B2 (en) | Motilin-like polypeptide and use thereof | |
AU1382488A (en) | Cyclic peptides and their preparation | |
AU5097790A (en) | Cyclopentenyl pyrimidines and methods of using same | |
AU3270589A (en) | Antiperspirant and method of making same | |
AU8427091A (en) | Gamma-carboxylase and methods of use | |
IL87730A0 (en) | Peptides and antibodies | |
AU610900B2 (en) | Immunosuppressant peptides | |
AU3890689A (en) | Human protein c mutants and method for preparing the same | |
AU576717B2 (en) | N6 - bicycloadenosines and methods of use | |
AU2584688A (en) | Sectional container and method of assembly thereof | |
AU3193089A (en) | Prepromotilin and motilin-associated peptide (map) | |
AU1966688A (en) | Immunosuppressive polypeptides | |
AU2623088A (en) | New anti-receptor peptides and therapeutic agents |